- Home
- NERV vs HLP Comparison
NERV vs HLP Comparison
Compare NERV & HLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- HLP
- Stock Information
- Founded
- NERV 2007
- HLP 2021
- Country
- NERV United States
- HLP China
- Employees
- NERV N/A
- HLP N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- HLP Industrial Machinery/Components
- Sector
- NERV Health Care
- HLP Industrials
- Exchange
- NERV Nasdaq
- HLP Nasdaq
- Market Cap
- NERV 18.3M
- HLP 15.5M
- IPO Year
- NERV 2014
- HLP 2023
- Fundamental
- Price
- NERV $2.20
- HLP $1.13
- Analyst Decision
- NERV Hold
- HLP
- Analyst Count
- NERV 1
- HLP 0
- Target Price
- NERV $5.00
- HLP N/A
- AVG Volume (30 Days)
- NERV 25.3K
- HLP 14.1K
- Earning Date
- NERV 11-05-2024
- HLP 11-26-2024
- Dividend Yield
- NERV N/A
- HLP N/A
- EPS Growth
- NERV N/A
- HLP N/A
- EPS
- NERV N/A
- HLP N/A
- Revenue
- NERV N/A
- HLP $14,045,084.00
- Revenue This Year
- NERV N/A
- HLP N/A
- Revenue Next Year
- NERV N/A
- HLP N/A
- P/E Ratio
- NERV N/A
- HLP N/A
- Revenue Growth
- NERV N/A
- HLP N/A
- 52 Week Low
- NERV $2.10
- HLP $0.72
- 52 Week High
- NERV $13.49
- HLP $5.54
- Technical
- Relative Strength Index (RSI)
- NERV 34.31
- HLP 37.50
- Support Level
- NERV $2.26
- HLP $1.10
- Resistance Level
- NERV $2.43
- HLP $1.31
- Average True Range (ATR)
- NERV 0.16
- HLP 0.09
- MACD
- NERV -0.01
- HLP 0.00
- Stochastic Oscillator
- NERV 13.71
- HLP 8.61
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll formed steel profile manufacturer in China. It customizes and manufactures cold roll formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture and transportation.